According to IMARC Group latest report titled “3D Bioprinting Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on 3D bioprinting market growth. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global 3D bioprinting market size reached US$ 1,032 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,621 Million by 2028, exhibiting a growth rate (CAGR) of 16.4% during 2023-2028.
Three-dimensional (3D) bioprinting is a form of additive manufacturing that utilizes cells and biomaterials to create biomedical parts that imitate the characteristics of natural tissue. It utilizes the layer-by-layer method, computed tomography (CT) and magnetic resonance imaging (MRI) to create tissue-like structures. It comprises several stages, including pre-bioprinting, bioprinting and post-bioprinting, which is employed for developing organ and tissue constructs that can be used for the manufacturing of drugs, scaffolds and medical implants. It is an emerging field represented by various biologically applied deposition and assembling systems, such as direct writing, photolithography, microstamping, laser writing, stereolithography, microfluidics and inkjet deposition.
Request to Get the Free Sample Report: https://www.imarcgroup.com/3d-bioprinting-market/requestsample
Market Trends:
One of the key factors driving the global market is the increasing prevalence of chronic disorders among the masses. Along with this, continuous technological advancements in numerous medical applications, such as cancer therapeutics, bone and cartilage, and skin tissue development, are anticipating the market. Moreover, the rising usage of 3D bioprinting in cosmetic surgeries is acting as another growth-inducing factor. Furthermore, the increasing funding by public and private agencies to improve the overall 3D bioprinting processes is creating a positive market outlook. Other factors, including the rising demand for organ transplants, increasing adoption of magnetic levitation technology for toxicity screening and vascular muscle printing, and ongoing research and development (R&D) activities, are also impacting the market.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/3d-bioprinting-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- 3D Systems Inc.
- Aspect Biosystems Ltd.
- Cellink, Cyfuse Biomedical K.K.
- EnvisionTEC GmbH (Desktop Metal Inc.)
- GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH
- Materialise
- Organovo Holdings Inc.
- Poietis, RegenHU
- Stratasys Ltd
3D Bioprinting Market Segmentation:
Our report has categorized the market based on region, component, application and end use industry.
Breakup by Component:
- 3D Bioprinters
- Syringe/Extrusion Bioprinting
- Inkjet Bioprinting
- Magnetic Levitation Bioprinting
- Laser-assisted Bioprinting
- Others
- Scaffolds
- Biomaterials
- Living Cells
- Hydrogels
- Extracellular Matrices
- Others
Breakup by Application:
- Research
- Drug Research
- Regenerative Medicine
- 3D Cell Culture
- Clinical
- Skin
- Bone and Cartilage
- Blood Vessels
- Others
Breakup by End User:
- Hospitals
- Research Organization and Academic Institutes
- Biopharmaceuticals Companies
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800